FASTING MIMICKING TECHNOLOGY

Serial Number 97364195
733

Registration Progress

Application Filed
Apr 14, 2022
Under Examination
Aug 1, 2023
Approved for Publication
Jun 6, 2023
Published for Opposition
Jun 6, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Feb 01, 2026 207 days

Basic Information

Serial Number
97364195
Deadline
February 1, 2026
Description
Statement of Use or 5th Extension Due
Filing Date
April 14, 2022
Published for Opposition
June 6, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Feb 19, 2025
Application
Pending
Classes
005 042

Rights Holder

L-Nutra Inc.

03
Address
5905 LEGACY DRIVE, 5TH FLOOR
PLANO, TX 75024

Ownership History

L-Nutra Inc.

Original Applicant
03
Plano, TX

L-Nutra Inc.

Owner at Publication
03
PLANO, TX

Legal Representation

Attorney
THOMAS J SPEISS III

USPTO Deadlines

Next Deadline
207 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
February 01, 2026
Extension Available
Until August 01, 2024

Application History

48 events
Date Code Type Description
Feb 20, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 19, 2025 EX4G S SOU EXTENSION 4 GRANTED
Feb 19, 2025 EXT4 S SOU EXTENSION 4 FILED
Feb 19, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 20, 2024 EXT3 S SOU EXTENSION 3 FILED
Oct 20, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 20, 2024 EX3G S SOU EXTENSION 3 GRANTED
Sep 12, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 12, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 12, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 12, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 12, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 11, 2024 EX2G S SOU EXTENSION 2 GRANTED
Jun 11, 2024 EXT2 S SOU EXTENSION 2 FILED
Jun 11, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
May 23, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 23, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 23, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 23, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 23, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 26, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 24, 2024 EX1G S SOU EXTENSION 1 GRANTED
Jan 24, 2024 EXT1 S SOU EXTENSION 1 FILED
Jan 24, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 1, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 6, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2023 PUBO A PUBLISHED FOR OPPOSITION
May 17, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 2, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED
May 1, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 1, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED
May 1, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN
Apr 8, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 7, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 7, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 7, 2022 GNRT F NON-FINAL ACTION E-MAILED
Oct 7, 2022 CNRT R NON-FINAL ACTION WRITTEN
Sep 26, 2022 DOCK D ASSIGNED TO EXAMINER
Sep 21, 2022 DOCK D ASSIGNED TO EXAMINER
Jun 8, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 8, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 8, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 20, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 18, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; Pharmaceutical preparations, namely, epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and prevention of cancer; pharmaceutical preparations for the treatment, diagnosis, detection and prevention of cancer; Pharmaceutical preparations, namely, biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer
Class 042
Research and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer; consultancy, advisory and information services relating to and connected with the aforementioned services

Additional Information

Other
as to "FASTING MIMICKING"

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"TECHNOLOGY"